Morphocell Technologies aims at transforming the treatment of severe liver diseases by the means of cell therapy. We are developing stem cell-derived engineered liver tissues to replace liver functions and treat several forms of liver disease.
Location: Canada
Total raised: $50M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 01.12.2025 | Series A | $50M | Investisse... |
Mentions in press and media 3
| Date | Title | Description |
| 01.12.2025 | Morphocell Technologies Raises US$50M in Series A Funding | Morphocell Technologies Inc., a Montreal, Canada-based biotechnology company advancing tissue therapeutics for organ replacement, raised US$10M in Series A extension funding. The round was led by Investissement Québec, and CDP Venture Capit... |
| 01.12.2025 | Morphocell Technologies: $50 Million Series A Raised To Advance Regenerative Medicine | Morphocell Technologies has completed a $50 million Series A financing following a US$10 million extension led by Investissement Québec and CDP Venture Capital. The closing brings the total Series A raise to $50 million after the company se... |
| - | Morphocell Technologies | “Morphocell Technologies aims at transforming the treatment of severe liver diseases by the means of cell therapy. We are developing stem cell-derived engineered liver tissues to replace liver functions and treat several forms of liver dise... |